Nascent Biotech, Inc. (NBIO) | 7.05% | $0.22M | N/A | N/A | N/A |
Vor Biopharma, Inc. (VOR) | 6.59% | $298.65M | N/A | N/A | N/A |
ProKidney Corp. (DNAC) | 3.60% | $1.08B | N/A | -501.74% | 3,779.12 |
MiNK Therapeutics, Inc. (INKT) | 2.72% | $161.86M | N/A | N/A | N/A |
Omega Therapeutics, Inc. (OMGA) | 2.20% | $3.55M | 214.32% | -18.64% | 20.35 |
Cognition Therapeutics, Inc. (CGTX) | 1.57% | $37.51M | N/A | N/A | N/A |
Seres Therapeutics, Inc. (MCRB) | 1.40% | $128.10M | N/A | N/A | N/A |
ImmunoPrecise Antibodies Ltd. (IPA) | 1.28% | $90.61M | -5.89% | 43.44% | 0.88 |
Aldeyra Therapeutics, Inc. (ALDX) | 1.15% | $300.08M | N/A | N/A | N/A |
C4 Therapeutics, Inc. (CCCC) | 1.05% | $149.82M | 138.17% | 72.19% | -0.94 |
SAB Biotherapeutics, Inc. (SABS) | 1.00% | $24.99M | -100.00% | N/A | 17.39 |
Spruce Biosciences, Inc. (SPRB) | 0.97% | $4.35M | -100.00% | N/A | -3.63 |
MeiraGTx Holdings Plc (MGTX) | 0.95% | $714.45M | 176.33% | -131.52% | 15.94 |
Ventyx Biosciences, Inc. (VTYX) | 0.95% | $199.96M | N/A | N/A | N/A |
Replimune Group, Inc. (REPL) | 0.94% | $869.54M | N/A | N/A | N/A |
Quince Therapeutics, Inc. (CRTX) | 0.94% | $78.66M | N/A | N/A | N/A |
Kodiak Sciences, Inc. (KOD) | 0.94% | $272.79M | N/A | N/A | N/A |
Athira Pharma, Inc. (ATHA) | 0.92% | $15.47M | N/A | N/A | N/A |
IO Biotech, Inc. (IOBT) | 0.92% | $112.00M | N/A | N/A | N/A |
Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.92% | $34.79M | N/A | -2,062.59% | 438.19 |
Agenus, Inc. (AGEN) | 0.92% | $187.26M | -14.07% | 86.12% | 4.57 |
Enzo Biochem, Inc. (ENZ) | 0.91% | $35.78M | -20.19% | 38.80% | -0.31 |
Precigen, Inc. (PGEN) | 0.90% | $575.60M | 25.92% | -5.82% | 93.45 |
Black Diamond Therapeutics, Inc. (BDTX) | 0.89% | $167.18M | N/A | 99.88% | -0.59 |
TScan Therapeutics, Inc. (TCRX) | 0.87% | $108.65M | 283.57% | 68.77% | 5.50 |
Foghorn Therapeutics, Inc. (FHTX) | 0.87% | $327.76M | 17.86% | 86.11% | 1.86 |
Larimar Therapeutics, Inc. (LRMR) | 0.86% | $220.90M | N/A | N/A | N/A |
Aspira Women's Health, Inc. (AWH) | 0.85% | $6.15M | 5.85% | 68.45% | 0.19 |
Neoleukin Therapeutics, Inc. (NLTX) | 0.85% | $320.54M | N/A | N/A | -37.87 |
BioXcel Therapeutics, Inc. (BTAI) | 0.84% | $12.23M | -71.13% | 46.43% | 45.74 |
Xeris Biopharma Holdings, Inc. (XERS) | 0.83% | $871.24M | 47.94% | 80.97% | 4.71 |
Galectin Therapeutics, Inc. (GALT) | 0.82% | $180.38M | N/A | N/A | N/A |
Trevi Therapeutics, Inc. (TRVI) | 0.81% | $835.20M | N/A | N/A | N/A |
Greenwich LifeSciences, Inc. (GLSI) | 0.80% | $144.51M | N/A | N/A | N/A |
Climb Bio, Inc. (ELYM) | 0.80% | $95.96M | N/A | N/A | N/A |
Monte Rosa Therapeutics, Inc. (GLUE) | 0.80% | $323.54M | 7,882.05% | 97.59% | 0.63 |
Enlivex Therapeutics Ltd. (ENLV) | 0.80% | $30.53M | N/A | N/A | N/A |
Solid Biosciences, Inc. (SLDB) | 0.79% | $424.01M | N/A | N/A | N/A |
Vistagen Therapeutics, Inc. (VTGN) | 0.79% | $69.40M | -54.32% | -30.66% | -3.66 |
23andMe Holding Co. (ME) | 0.78% | $133.58M | -13.54% | 40.37% | -0.10 |
XBiotech, Inc. (XBIT) | 0.78% | $88.11M | N/A | N/A | N/A |
Elutia, Inc. (AZYO) | 0.77% | $84.29M | -9.92% | 40.75% | 5.33 |
Graphite Bio, Inc. (GRPH) | 0.77% | $901.79M | N/A | N/A | N/A |
AVROBIO, Inc. (AVRO) | 0.76% | $400.31M | N/A | N/A | N/A |
Nuvation Bio, Inc. (NUVB) | 0.76% | $724.76M | N/A | 22.05% | 13.30 |
Adaptimmune Therapeutics Plc (ADAP) | 0.76% | $72.46M | 28.87% | 54.08% | 0.22 |
LAVA Therapeutics NV (LVTX) | 0.75% | $38.93M | -100.00% | N/A | -6.43 |
Reneo Pharmaceuticals, Inc. (RPHM) | 0.75% | $33.74M | N/A | N/A | N/A |
Bionano Genomics, Inc. (BNGO) | 0.74% | $11.40M | -26.37% | 45.50% | -0.12 |
Sangamo Therapeutics, Inc. (SGMO) | 0.74% | $122.70M | 1,238.25% | 70.11% | 2.26 |
Design Therapeutics, Inc. (DSGN) | 0.74% | $227.07M | N/A | N/A | N/A |
Seer, Inc. (California) (SEER) | 0.74% | $123.58M | 37.15% | 49.01% | -7.47 |
Ikena Oncology, Inc. (IKNA) | 0.74% | $66.11M | N/A | N/A | N/A |
Voyager Therapeutics, Inc. (VYGR) | 0.73% | $189.80M | -66.83% | 84.33% | 0.05 |
iTeos Therapeutics, Inc. (ITOS) | 0.73% | $396.13M | N/A | N/A | -7.35 |
Nkarta, Inc. (NKTX) | 0.73% | $129.14M | N/A | N/A | N/A |
InflaRx NV (IFRX) | 0.72% | $59.88M | -100.00% | N/A | -32.37 |
Kezar Life Sciences, Inc. (KZR) | 0.72% | $33.46M | N/A | N/A | N/A |
Co-Diagnostics, Inc. (CODX) | 0.72% | $8.94M | -80.11% | -500.74% | -16.96 |
Taysha Gene Therapies, Inc. (TSHA) | 0.72% | $656.44M | -32.51% | 87.71% | 44.20 |
Heron Therapeutics, Inc. (HRTX) | 0.72% | $323.43M | 12.21% | 78.26% | 3.77 |
Spyre Therapeutics, Inc. (AGLE) | 0.72% | $924.01M | N/A | N/A | N/A |
Vigil Neuroscience, Inc. (VIGL) | 0.72% | $384.83M | N/A | N/A | N/A |
Stoke Therapeutics, Inc. (STOK) | 0.72% | $641.51M | 3,661.12% | 99.32% | 0.22 |
CARA Therapeutics, Inc. (CARA) | 0.71% | $39.81M | 20.33% | N/A | 4.59 |
Nautilus Biotechnology, Inc. (NAUT) | 0.71% | $99.37M | N/A | N/A | N/A |
Vaxxinity, Inc. (VAXX) | 0.71% | $0.01M | N/A | N/A | N/A |
AlloVir, Inc. (ALVR) | 0.71% | $44.89M | N/A | N/A | N/A |
Cue Biopharma, Inc. (CUE) | 0.70% | $58.55M | -75.48% | -109.26% | 7.71 |
Century Therapeutics, Inc. (IPSC) | 0.70% | $49.83M | 12,667.72% | 97.05% | -0.62 |
Verastem, Inc. (VSTM) | 0.70% | $272.55M | N/A | N/A | 28.59 |
Humacyte, Inc. (HUMA) | 0.70% | $383.14M | N/A | -282.79% | 471.70 |
uniQure NV (QURE) | 0.69% | $796.59M | -81.53% | -201.47% | 33.01 |
BioAtla, Inc. (BCAB) | 0.69% | $23.01M | N/A | N/A | -1.06 |
Compugen Ltd. (CGEN) | 0.68% | $148.69M | -10.75% | -5.08% | 1.22 |
Gain Therapeutics, Inc. (GANX) | 0.68% | $55.70M | N/A | N/A | N/A |
Immunome, Inc. (IMNM) | 0.68% | $740.47M | 184.35% | 75.19% | 20.29 |
HCW Biologics Inc. (HCWB) | 0.67% | $10.43M | -99.55% | -8,252.66% | 17.60 |
Fate Therapeutics, Inc. (FATE) | 0.67% | $129.54M | -15.38% | -104.60% | -4.77 |
Prelude Therapeutics, Inc. (PRLD) | 0.67% | $46.24M | N/A | N/A | -3.26 |
Anixa Biosciences, Inc. (ANIX) | 0.67% | $103.08M | N/A | N/A | N/A |
Champions Oncology, Inc. (CSBR) | 0.66% | $110.20M | 41.77% | 61.17% | 2.75 |
Carisma Therapeutics, Inc. (SESN) | 0.66% | $18.84M | 9.77% | 58.76% | 0.38 |
Precision BioSciences, Inc. (DTIL) | 0.66% | $51.45M | -99.84% | -2,331.03% | -0.06 |
Whitehawk Therapeutics, Inc. (AADI) | 0.65% | $96.57M | 33.48% | 89.36% | -5.76 |
Invivyd, Inc. (ADGI) | 0.65% | $81.87M | N/A | 86.09% | 0.69 |
HOOKIPA Pharma, Inc. (HOOK) | 0.64% | $14.64M | -94.52% | 80.59% | -2.81 |
Mersana Therapeutics, Inc. (MRSN) | 0.63% | $42.75M | -70.21% | 88.53% | -1.03 |
Leap Therapeutics, Inc. (LPTX) | 0.63% | $13.68M | N/A | N/A | N/A |
Instil Bio, Inc. (TIL) | 0.61% | $160.65M | N/A | N/A | N/A |
PepGen Inc. (PEPG) | 0.60% | $42.21M | N/A | N/A | N/A |
Rani Therapeutics Holdings, Inc. (RANI) | 0.60% | $44.14M | N/A | -45.93% | 40.96 |
Curis, Inc. (CRIS) | 0.60% | $22.56M | 14.09% | 96.93% | 2.85 |
CorMedix, Inc. (CRMD) | 0.59% | $845.52M | N/A | 95.91% | 4.21 |
Shattuck Labs, Inc. (STTK) | 0.58% | $39.28M | -100.00% | N/A | -2.02 |
Spero Therapeutics, Inc. (SPRO) | 0.58% | $147.60M | 21.57% | N/A | -0.18 |
ImmuCell Corp. (ICCC) | 0.58% | $58.74M | 11.16% | 41.58% | 1.94 |
Renovaro, Inc. (ENOB) | 0.58% | $48.35M | N/A | N/A | N/A |
Compass Pathways Plc (CMPS) | 0.54% | $344.47M | N/A | N/A | N/A |
Passage Bio, Inc. (PASG) | 0.54% | $18.58M | N/A | N/A | N/A |
BioVie, Inc. (BIVI) | 0.48% | $12.29M | N/A | N/A | N/A |
eFFECTOR Therapeutics, Inc. (EFTR) | 0.47% | $0.00M | -100.00% | N/A | N/A |
Insight Molecular Diagnostics, Inc. (OCX) | 0.46% | $81.22M | 1,114.77% | 40.27% | 13.29 |
Vaxart, Inc. (VXRT) | 0.45% | $98.17M | 857.18% | 94.73% | 1.51 |
Jasper Therapeutics, Inc. (JSPR) | 0.45% | $52.13M | N/A | N/A | N/A |
Quanterix Corp. (QTRX) | 0.45% | $256.14M | -5.40% | 65.91% | 0.16 |
Altimmune, Inc. (ALT) | 0.42% | $345.52M | N/A | -480.00% | 11,472.89 |
X4 Pharmaceuticals, Inc. (XFOR) | 0.39% | $8.57M | N/A | 82.63% | 1.27 |
Affimed NV (AFMD) | 0.24% | $0.59M | -92.02% | N/A | 43.85 |
INmune Bio, Inc. (INMB) | 0.23% | $56.36M | 257.14% | N/A | 3,134.11 |
Syros Pharmaceuticals, Inc. (SYRS) | 0.08% | $0.80M | -100.00% | N/A | 224.15 |